User
Favorite list
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
November 8, 2019
9:00 a.m.–5:00 p.m.
Panum Institute, Lundsgaard auditorium, Copenhagen
Attendance is free of charge.
To register, please click here.
Miltenyi Biotec invites you to join a scientific day on the topic of cell and immune therapy. The cellular therapy field is growing immensely with new treatments and applications arising every day. We believe that the possibilities for future treatments are endless and with hundreds of clinical trials the journey has just started. The Nordics, and Medicon Valley in particular, is an innovative region with a big scientific collaborative environment between the private and academic sector. With this scientific day we aim to bring researchers, clinicians and the industry closer together and foster interaction, networking and new great ideas that can become reality.
Agenda
| 09:00 a.m. | Registration and coffee |
| 09:30 a.m. | Welcome/ Miltenyi Biotec overview Martin Schalén, Marketing Manager, Miltenyi Biotec Nordics |
Regenerative medicine session | |
| 09:45 a.m. | From autologous to allogeneic stem cell therapy in heart disease Jens Kastrup, Professor and Director of Cardiac Stem Cell Centre, Rigshospitalet, Copenhagen |
| 10:15 a.m. | Ex vivo expansion of mobilized hematopoietic stem cells after immunomagnetic isolation Bjarne Kuno Möller, Clinical Professor, Department of Immunology, Aarhus University |
| 10:45 a.m. | Coffee break |
| 11:30 a.m. | Bringing hESCs to the clinic for treatment of Parkinson’s Disease Agnete Kirkeby, Associate Professor of Stem Cell Biology, Center for Stem Cell Research and Developmental Biology (DanStem), Copenhagen University |
| 12:00 p.m. | Tissue-typed term amniotic fluid MSCs for ATMP production Jan Talts, COO, Longboat Amniotics |
| 12:30 p.m. | Lunch and networking |
Immune therapy session | |
| 01:30 p.m. | CAR-T cells in malignant melanoma: on the path to clinical trials Jonas Nilsson, Director at Sahlgrenska Cancer Center and Professor of Experimental Cancer Surgery, Gothenburg University |
| 02:00 p.m. | Engineering of NK cells to improve their homing capacity Melanie Lambert, PostDoc, Mattias Carlsten Group, Karolinska Institute |
| 02:30 p.m. | Coffee and cake |
| 03:15 p.m. | TBA Katja Puttonen, Head of Process Development, Kuopio Center for Gene and Cell Therapy |
| 03:45 p.m. | AdaptNK: An off-the-shelf cell therapy against refractory leukemia Andreas Björklund, Associated Professor, Unit for Cell therapy and Allogeneic Stem Cell Transplantation, Department of Medicine, Huddinge, Karolinska institutet/Ebba Sohlberg, PhD, Project Manager, Centrum för infektionsmedicin, Malmberg group, Karolinska institutet |
| 04:15 p.m. | Onwards – Wrap up, bubbles and networking |
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.
